Skip to content

Clinical trials

Completed Carcinoma, Non-Small-Cell Lung trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Completed Country / region: South Korea Clear all

267 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20045
20054
20068
20079
200811
200913
201014
201115
201212
201316
201421
201520
201615
201718
201824
201917
202018
20219
20225
20237
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed267

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche27
AstraZeneca25
Eli Lilly and Company19
Novartis Pharmaceuticals15
Pfizer15
Boehringer Ingelheim14
Merck Sharp & Dohme LLC12
Samsung Medical Center8
Bristol-Myers Squibb7
EMD Serono Research & Development Institute, Inc.6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung267
Lung Neoplasms41
Neoplasms36
Neoplasm Metastasis12
Colorectal Neoplasms10
Breast Neoplasms8
Adenocarcinoma7
Adenocarcinoma of Lung7
Carcinoma7
Carcinoma, Renal Cell6

Trials

Showing 1 to 25 of 267. Each trial links to its page on Pharma Observatory.

167 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.